Discovery Of Novel Heart Failure Therapeutics Via Development Of A Next Generation Therapeutic Screening Platform: Force-generating Human Heart Tissue Micro-arrays
Funder
National Health and Medical Research Council
Funding Amount
$463,524.00
Summary
In this project we will develop a micro scale platform containing 384 miniature human heart muscle strips. The technology we develop will enable us to determine the strength of the contraction of each strip which is a model of heart function. This provides us a platform to better understand heart disease and also to screen for new drugs for heart failure.
Containment Potential And Risk Of Spread Of Artemisinin Resistant Plasmodium Falciparum
Funder
National Health and Medical Research Council
Funding Amount
$381,762.00
Summary
Significant gains have been made in the past decade in reducing falciparum malaria morbidity and mortality using artemisinin-base combination therapy (ACT) and insecticidal nets. However the recent emergence of artemisinin resistance threatens these achievements. This project will develop and use a mathematical model of malaria transmission incorporating resistance to the drugs in ACTs to investigate the probability and rate of spread of resistance into new areas endemic for malaria.
Human Olfactory Neurosphere-derived Cells: A Novel Cellular Model For Parkinson's Disease.
Funder
National Health and Medical Research Council
Funding Amount
$365,126.00
Summary
ParkinsonÍs disease (PD) is an incurable, brain disease that affects 75,000 Australians with great societal cost. We are working on adult stem cells called (hONS) grown from peopleÍs olfactory mucosa (in the nose) as a research tool to study PD. Our project examines differences seen in hONS from people with PD and determines how certain cellular processes impact on the function of these cells. This work will enhance our understanding of the biology of PD and identify new targets for therapies.
Using An Established Simulation Model To Determine Effective And Cost-effective Interventions To Mitigate Influenza Pandemics And Inform Public Health Policy
Funder
National Health and Medical Research Council
Funding Amount
$416,353.00
Summary
A novel disease spread and economic model is used to determine the cost-effectiveness of a range of mitigation strategies aimed at a future influenza pandemic. A simulation model generates data on which individuals become ill, morbidity and mortality characteristics, an economic costing model determines optimal interventions.
AusGo-SHEMO….Let’s Go! Australian Gold Standard Health Economics Model Of Osteoporosis
Funder
National Health and Medical Research Council
Funding Amount
$378,959.00
Summary
We will develop an unbiased, gold standard, validated, transparent health economics model of osteoporosis to identify cost-effective screening and treatment strategies, and that will be made widely available to all stakeholders. Without this model, scarce health care resources may be squandered on osteoporosis screening strategies and osteoporosis-related fracture prevention medications that are not cost-effective. Worse, patient access to cost-effective medications may be delayed.
Dynamic Action Potential Clamp Studies Of Drugs That Affect The Cardiac Action Potential
Funder
National Health and Medical Research Council
Funding Amount
$343,976.00
Summary
The development of drugs to treat and.or prevent cardiac arrhythmias have been plagued by the side-effect of actually increasing the risk of sudden death. One of the reasons for this is that drugs that work well in one part of the heart may cause problems in another part. We are developing a system called “dynamic action potential clamp” that will make it easier for researchers to assess the effect of drugs in different regions of both normal and diseased hearts.
Applying Quantitative Immunology To The Analysis Of Complex Genetic Diseases
Funder
National Health and Medical Research Council
Funding Amount
$864,596.00
Summary
The immune response of each individual varies. For some, the response invoked by foreign challenge is weak, leading to a lifetime of difficulty with infection. For others, the response is stronger, yielding excellent immunity, but opening the potential for overactive responses to self-material and autoimmune disease. We have a new theory for how the health of our immune system can be measured and we aim to apply it to understand the genesis of the many different forms of human immune diseases.
Bridging The Gap Between Cartilage Biology And Osteoarthritis Risk Prediction
Funder
National Health and Medical Research Council
Funding Amount
$512,256.00
Summary
Osteoarthritis is a painful and debilitating cartilage disease affecting just under 1 in 10 Australians and costs the Australian economy roughly $12 billion per year. This project will develop computational models of cartilage with the ability to incorporate genetic and environmental risk factors into a predictive model of cartilage disease.
Implications Of The Increasing Duration Of Life Spent With Obesity For Population Health
Funder
National Health and Medical Research Council
Funding Amount
$251,830.00
Summary
As the prevalence of obesity at younger ages increases, people are living longer with obesity. We have recently shown that this has an increased risk of mortality and diabetes. In this project we will look at the extent to which an increasing length of time lived with obesity is also associated with increased risks of hypertension, heart disease, cancer, arthritis and disability. We will also look at the effect of this increasing duration on the overall health of Australian adults.
Mechanisms Of Propagation And Containment Of Gene Silencing
Funder
National Health and Medical Research Council
Funding Amount
$272,223.00
Summary
Long-term and heritable repression of genes by epigenetic mechanisms is essential for health but can also be dangerous if it goes wrong. Mathematical modelling and biochemical experiments will be used to understand how this gene silencing propagates and spreads along the DNA, and how it can be stopped from spreading too far.